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Background: Endothelial dysfunction (EDF) has been proposed as a strong marker of cardiovascular disease (CVD) risk. However, individual 
studies are small and do not allow reliable quantification of the strength of association.
Methods: We conducted a literature-based meta-analysis of available studies that had reported on EDF and CVD. Our inclusion criteria were 
studies which: described methods to assess endothelial function; recorded CVD outcomes; had ≥12 months follow up. Effect estimates for CVD were 
standardized across studies by comparing top 3rd vs. bottom 3rd of EDF. Study-specific relative risks (RR) were combined using random-effects 
meta-analysis.
Results: Thirty-three studies, involving 16,717 participants (> 74,000 person years follow-up) were eligible, reporting on 2,376 CVD events. The risk 
of CVD among those in the top vs. bottom third of EDF was 1.25 (95% CI, 1.15-1.36) with considerable heterogeneity across studies (I2 = 71%, p < 
0.001). The effects were stronger among those with existing disease or among those with high risk factor burden compared with healthy individuals 
(p for interaction < 0.001). There was considerable publication bias as assessed by funnel plots and Egger’s test.
Conclusion: In this largest study to date, EDF was found to be a significant but more modest predictor of CVD outcomes than previously reported. 
Significant publication bias and heterogeneity across studies suggest any potential clinical utility is premature.
